ICON Public Limited Company (ICLR) est une société cotée en bourse dans le Santé secteur, opérant dans le Medical - Diagnostics & Research secteur d'activité. Le siège social de l'entreprise est situé à Dublin, Ireland. Le PDG actuel est Barry Balfe.
ICLR a date d'introduction en bourse 1998-05-15, 41,250 employés à temps plein, cotée sur le NASDAQ Global Select, une capitalisation boursière de $8.63B.
ICON Public Limited Company is a clinical research organization headquartered in Dublin, Ireland, that provides comprehensive outsourced development and commercialization services to the pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company specializes in managing the full spectrum of clinical development from compound selection through Phase I-IV clinical studies, offering services including early-stage development, patient recruitment, data management, biostatistics, medical writing, regulatory strategy, and pharmacovigilance. With a global presence across Ireland, Europe, the United States, and internationally, ICON delivers integrated solutions encompassing clinical development, medical imaging, laboratory services, site monitoring, and consulting and analytics support. Founded in 1990, the company has established itself as a key partner in accelerating drug development and bringing new therapeutics to market.
